SG11202109705YA - Method for treating female non-smokers with non-small cell lung cancer - Google Patents

Method for treating female non-smokers with non-small cell lung cancer

Info

Publication number
SG11202109705YA
SG11202109705YA SG11202109705YA SG11202109705YA SG 11202109705Y A SG11202109705Y A SG 11202109705YA SG 11202109705Y A SG11202109705Y A SG 11202109705YA SG 11202109705Y A SG11202109705Y A SG 11202109705YA
Authority
SG
Singapore
Prior art keywords
smokers
lung cancer
small cell
cell lung
treating female
Prior art date
Application number
Other languages
English (en)
Inventor
Aditya Kulkami
Arun Asaithambi
Original Assignee
Lantern Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lantern Pharma Inc filed Critical Lantern Pharma Inc
Publication of SG11202109705YA publication Critical patent/SG11202109705YA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
  • Epoxy Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG11202109705Y 2019-03-08 2020-03-08 Method for treating female non-smokers with non-small cell lung cancer SG11202109705YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962815762P 2019-03-08 2019-03-08
PCT/US2020/021615 WO2020185640A1 (en) 2019-03-08 2020-03-08 Method for treating female non-smokers with non-small cell lung cancer

Publications (1)

Publication Number Publication Date
SG11202109705YA true SG11202109705YA (en) 2021-10-28

Family

ID=72427123

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202109705Y SG11202109705YA (en) 2019-03-08 2020-03-08 Method for treating female non-smokers with non-small cell lung cancer

Country Status (11)

Country Link
US (1) US20220168258A1 (zh)
EP (1) EP3935043A4 (zh)
JP (1) JP2022525040A (zh)
KR (1) KR20220047208A (zh)
CN (1) CN113906010A (zh)
AU (1) AU2020235823A1 (zh)
BR (1) BR112021017716A2 (zh)
CA (1) CA3132827A1 (zh)
MX (1) MX2021010745A (zh)
SG (1) SG11202109705YA (zh)
WO (1) WO2020185640A1 (zh)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009113989A1 (en) * 2008-03-14 2009-09-17 Bionumerik Pharmaceuticals, Inc. Compositions and methods of use of compounds to increase cancer patient survival time
JP5694782B2 (ja) * 2008-03-14 2015-04-01 バイオニューメリック・ファーマスーティカルズ・インコーポレイテッド 肺癌、腺癌及び他の病状のための治療方法及び組成物
US20170007561A1 (en) * 2014-08-08 2017-01-12 Bionumerik Pharmaceuticals, Inc. Contemporaneous, heterogeneously-oriented, multi-targeted therapeutic modification and/or modulation of disease by administration of sulfur-containing, amino acid-specific small molecules

Also Published As

Publication number Publication date
BR112021017716A2 (pt) 2021-11-16
JP2022525040A (ja) 2022-05-11
AU2020235823A1 (en) 2021-11-04
CN113906010A (zh) 2022-01-07
KR20220047208A (ko) 2022-04-15
WO2020185640A1 (en) 2020-09-17
EP3935043A1 (en) 2022-01-12
CA3132827A1 (en) 2020-09-17
EP3935043A4 (en) 2023-01-11
MX2021010745A (es) 2021-12-15
US20220168258A1 (en) 2022-06-02

Similar Documents

Publication Publication Date Title
IL276481B (en) Anti-b7-h1 and anti-ctla-4 antibodies for the treatment of non-small cell lung cancer
EP3976195A4 (en) METHOD FOR TREATING SMALL CELL NEUROENDOCRINE CARCINOMA AND ASSOCIATED CARCINOMA
HK1247577A1 (zh) Egfr突變陽性的非小細胞肺癌的聯合療法
HK1252370A1 (zh) 用於治療非小細胞肺癌的治療方法和組合物
IL235459A0 (en) Ways to treat non-small cell lung cancer
EP3231797A4 (en) Quinoline derivative against non-small cell lung cancer
EP3137086A4 (en) Method of treating resistant non-hodgkin lymphoma, medulloblastoma, and/or alk+non-small cell lung cancer using thienotriazolodiazepine compounds
HK1247578A1 (zh) 用於治療非小細胞肺癌的組合抗pd-l1和抗ctla4抗體
ZA201309254B (en) Method for treating non-small cell lung cancer
EP3278889A4 (en) Rolling method for boards with different longitudinal thicknesses
EP3590534A4 (en) METHOD OF TREATMENT OF EGFR-TKI RESISTANT NON-SMALL CELL LUNG CANCER BY ADMINISTRATION OF ANTI-3-ANTIBODY ACTIVE CONJUGATE
IL262656A (en) Nanoliposomal irinotecan for use in the treatment of small cell lung cancer
EP3931564A4 (en) METHODS OF TREATMENT OF MAP3K8 POSITIVE TUMORS
EP4017489A4 (en) KRAS-ASSOCIATED CANCERS TREATMENT METHOD
IL276406A (en) Osimertinib for use in the treatment of non-small cell lung cancer
IL287907A (en) Cancer treatment methods
EP3820461A4 (en) METHODS OF TREATMENT OF CANCER
EP3969121A4 (en) METHODS AND COMPOSITIONS FOR TREATING NON-SMALL CELL LUNG CANCER
IL280800A (en) A method for treating pancreatic cancer
ZA202107342B (en) Chiauranib for treatment of small cell lung cancer
EP3880216A4 (en) METHODS OF TREATING CANCER WITH MANUFACTURED T LYMPHOCYTES
EP3894861A4 (en) DETECTION OF BIOMARKERS FOR NON-SMALL CELL LUNG CANCER
SG11202109705YA (en) Method for treating female non-smokers with non-small cell lung cancer
EP3538142A4 (en) ANTI-PD-L1 AND ANTI-CTLA-4 ANTIBODIES FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER
GB201918313D0 (en) Cells for treating cancer